Drug Patent Expirations for the Week of August 20, 2023

VYVANSE (lisdexamfetamine dimesylate) Takeda pharms usa Patent: 7,718,619 Expiration: Aug 24, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…

The post Drug Patent Expirations for the Week of August 20, 2023 appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.